Literature DB >> 22207134

Fine-tuning of proximal TCR signaling by ZAP-70 tyrosine residues in Jurkat cells.

M Szabo1, T Czompoly, K Kvell, G Talaber, D Bartis, P Nemeth, T Berki, F Boldizsar.   

Abstract

Zeta-chain-associated protein kinase of 70kDa (ZAP-70) kinase is a key regulator in the early steps of TCR signaling but some aspects of its fine regulation are still unclear. From its 31 tyrosine (Y) residues, 11 phosphorylation sites have been identified, some with activator (Y315 and Y493) or inhibitory (Y292 and Y492) and others with unknown function (Y069, Y126 and Y178). In our present work, we aimed to elucidate the role of different Y residues of ZAP-70, especially those with unknown function, in calcium signaling and the autoregulation of the kinase. ZAP-70-deficient Jurkat cells (P116) were stably reconstituted with point-mutated ZAP-70 constructs where tyrosine residues 069, 126, 178, 238, 292, 315, 492 or 493 were replaced with phenylalanine (F). The anti-CD3-elicited calcium signal increased in F069-, F292- and F492-ZAP-70-expressing cell lines but decreased in the F126-, F315- and F493-ZAP-70-expressing cell lines. ZAP-70 point mutations led to phosphorylation changes predominantly in SH2 domain containing leukocyte protein of 76kDa (SLP-76) but not linker of activated T cells (LAT) during CD3-activation; moreover, we detected basal hyperphosphorylation of SLP-76 Y128 in the F126-, F178- and F492-ZAP-70-expressing cell lines. In summary, Y069, Y178, Y292 and Y492 have inhibitory, while Y126, Y315 and Y493 activator role in anti-CD3-induced T-cell activation. Phosphorylation changes in LAT and SLP-76 suggest that fine regulation of ZAP-70 on calcium signaling is rather transmitted through SLP-76 not LAT. Additionally, negative or positive autoregulatory function of Y292 and Y493 or Y315, respectively, was revealed in ZAP-70. These data indicate that previously not characterized Y069, Y126 and Y178 in ZAP-70 participate in the fine regulation of TCR signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207134     DOI: 10.1093/intimm/dxr105

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs.

Authors:  Xue Wang; Jiying Tan; Jiangqin Zhao; Viswannath Ragupathy; Mohan Haleyurgirisetty; Indira Hewlett
Journal:  Mol Cell Biochem       Date:  2014-04-22       Impact factor: 3.396

2.  Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70T293 and destabilization of the signalosome.

Authors:  Maria Letizia Giardino Torchia; Debjani Dutta; Paul R Mittelstadt; June Guha; Matthias M Gaida; Kamonwan Fish; Valarie A Barr; Itoro O Akpan; Lawrence E Samelson; Harichandra D Tagad; Subrata Debnath; Lisa M Miller Jenkins; Ettore Appella; Jonathan D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

3.  A cycle of Zap70 kinase activation and release from the TCR amplifies and disperses antigenic stimuli.

Authors:  Zachary B Katz; Lucie Novotná; Amy Blount; Björn F Lillemeier
Journal:  Nat Immunol       Date:  2016-11-21       Impact factor: 25.606

4.  Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.

Authors:  R F Dielschneider; W Xiao; J-Y Yoon; E Noh; V Banerji; H Li; A J Marshall; J B Johnston; S B Gibson
Journal:  Cell Death Dis       Date:  2014-10-02       Impact factor: 8.469

Review 5.  Regulating the discriminatory response to antigen by T-cell receptor.

Authors:  Kaustav Gangopadhyay; Swarnendu Roy; Soumee Sen Gupta; Athira C Chandradasan; Subhankar Chowdhury; Rahul Das
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

6.  Erythroid Differentiation Regulator 1 Strengthens TCR Signaling by Enhancing PLCγ1 Signal Transduction Pathway.

Authors:  Myun Soo Kim; Dongmin Park; Sora Lee; Sunyoung Park; Kyung Eun Kim; Tae Sung Kim; Hyun Jeong Park; Daeho Cho
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.